Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro - Wikidata - awgldk - TriplyDB

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

http://www.wikidata.org/entity/Q36508920

about

Immunomodulation with rabbit anti-thymocyte globulin in solid organ transplantation Inducing and Administering Tregs to Treat Human Disease Biologics in organ transplantation Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation for adult T-cell leukemia/lymphoma Targeting of natural killer cells by rabbit antithymocyte globulin and campath-1H: similar effects independent of specificity A comprehensive review of immunosuppression used for liver transplantation.Immune reconstitution following rabbit antithymocyte globulin.Immune tolerance induction by integrating innate and adaptive immune regulators.Conditioning regimens for hematopoietic cell transplantation: one size does not fit all Efforts to prevent and halt autoimmune beta cell destruction.Apoptotic effects of antilymphocyte globulins on human pro-inflammatory CD4+CD28- T-cells.Anti-thymocyte globulin (ATG) differentially depletes naïve and memory T cells and permits memory-type regulatory T cells in nonobese diabetic mice.Prolonged, low-dose anti-thymocyte globulin, combined with CTLA4-Ig, promotes engraftment in a stringent transplant model.A comprehensive and quantitative analysis of the major specificities in rabbit antithymocyte globulin preparations.Efficacy of rabbit anti-thymocyte globulin in severe aplastic anemia.Immune-mediated bone marrow failure in C57BL/6 mice Conditioning with rabbit versus horse ATG dramatically alters clinical outcomes in identical twins with severe aplastic anemia transplanted with the same allogeneic donor T cells in the control of organ-specific autoimmunity Allogeneic hematopoietic stem cell transplantation in China: where we are and where to go.Graves disease following rabbit antithymocyte globulin treatment of severe aplastic anemia in a Korean child.In vivo effects of horse and rabbit antithymocyte globulin in patients with severe aplastic anemia.Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia.Long-term lung transplantation in nonhuman primates.Rabbit antithymocyte globulin (thymoglobulin) impairs the thymic output of both conventional and regulatory CD4+ T cells after allogeneic hematopoietic stem cell transplantation in adult patients.Current and future immunomodulation strategies to restore tolerance in autoimmune diseases.A novel multi-drug metronomic chemotherapy significantly delays tumor growth in mice.Sequential monitoring and stability of ex vivo-expanded autologous and nonautologous regulatory T cells following infusion in nonhuman primates.Validation of a multicolor staining to monitor phosphoSTAT5 levels in regulatory T-cell subsets.Regulatory T Cell Infusion Can Enhance Memory T Cell and Alloantibody Responses in Lymphodepleted Nonhuman Primate Heart Allograft Recipients Horse versus rabbit antithymocyte globulin in acquired aplastic anemia Immunosuppression for myelodysplastic syndrome: how bench to bedside to bench research led to success Mechanisms of action of antithymocyte globulin: old dogs with new tricks!Depleting T-cell subpopulations in organ transplantation.Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients.The effect of metronomic versus standard chemotherapy on the regulatory to effector T-cell equilibrium in cancer patients.Anti-thymocyte globulin as graft-versus-host disease prevention in the setting of allogeneic peripheral blood stem cell transplantation: a review from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.Improved nonrelapse mortality and infection rate with lower dose of antithymocyte globulin in patients undergoing reduced-intensity conditioning allogeneic transplantation for hematologic malignancies.Long-term outcome after immunosuppressive therapy with horse or rabbit antithymocyte globulin and cyclosporine for severe aplastic anemia in children.Manipulation of regulatory T-cell function by immunomodulators: a boon or a curse?Use of G-CSF-stimulated marrow in allogeneic hematopoietic stem cell transplantation settings: a comprehensive review.

P2860

Q26771391-B9661E19-E5B4-43B6-BD75-48324E1EAFB3 Q26772723-8BAD2D6A-0CB2-4177-A129-C4294F3A54BC Q26829578-F19F4E97-407E-4D97-9D10-19B6AE1A17B8 Q28072320-107DB4FC-9679-4E9B-B5D4-BF54DA8639EA Q33415472-A24966C7-6633-430D-ABBB-AA0A7C473CB0 Q33602527-D565F958-3A62-4BF1-ABA0-0F16520CA8A7 Q33827314-79129500-9CA6-4E86-BF88-991679B9F2AA Q33907609-F6DB5AAA-223F-4D86-A4B7-15918688744C Q33917170-DEAAA929-B9BE-476E-884F-564F4B7A3E71 Q34077363-1EEDCB44-C217-479A-AE2D-AAD4010E0111 Q34221820-F078D34F-676E-4E0B-9227-3A1E36ED2C2A Q34511576-8FF58D96-1AC5-4B38-A237-48BC136E55CD Q34551797-CBAEE83B-5EEC-4B40-9C54-7652282C870E Q35028105-E3E12744-20F0-48E4-9A75-BA653CD9D0D2 Q35193715-F6EC98AD-4633-457D-BDD6-6C01D71C5CBD Q35230019-8C8A4447-1D16-4918-B53E-7D3D3D990AE8 Q35805248-0BECC09A-4EB3-4FC9-A9F3-B2761B509AF5 Q35836118-1D08087A-300E-4E07-A615-33AF712B864A Q35965199-7658025C-C874-4783-96B4-F131F4F6F26B Q35976451-9EE04989-584E-462A-92DF-8884BA734260 Q36036288-65AE3519-CB1F-43F0-BC77-C7A6B2AF78E6 Q36038886-E757B818-ECAF-47BC-9C58-E55904B645E5 Q36044857-B231FA4F-818F-4914-A428-BB5FC1DA6BA5 Q36498340-DC3F777A-985D-4993-A918-D997C224977F Q36506677-C3F2C23B-EF0E-4E1A-9DF9-17115F75246F Q36616446-62D687A3-A197-4599-A9E3-E1B6F176D2C0 Q36638732-10DCA07F-C93B-4134-9A7F-FBA69969E294 Q36685390-6A6C894C-633D-4F34-AF15-E3BB59E8B246 Q37033965-EDF7B8DE-B125-46B2-A293-CD2DFCA99795 Q37040881-6EF0A0EF-8F72-4586-84D1-08F550E1F03A Q37222206-9AAC91AA-1741-4F80-ACBF-AE0D512A0A00 Q37271825-1EE6CE7B-F921-41DB-A4A1-85B33207CC76 Q37316082-4C7F6CF0-E14E-42C4-A199-F5A09852A90F Q37355472-5ED34601-39EF-4F95-9D33-6777C26ED74B Q37531844-42AC4E05-43B1-4421-AB26-AD058DBA64AB Q37618811-C6FE4F0A-0B9A-4BC9-88B0-AFC3EAE617EF Q37635642-CCDFBB43-2206-4B4A-BDB6-CADF48104E9A Q37676274-05ECFA42-7B2A-4E76-BDF0-038B59F8892F Q37756417-DE21A44D-6069-412B-983B-478F86332796 Q37772229-743D7C00-CED7-4F29-8511-08E4F74E7EFF

P2860

Rabbit ATG but not horse ATG promotes expansion of functional CD4+CD25highFOXP3+ regulatory T cells in vitro

http://www.wikidata.org/entity/Q36508920

description

2008 nî lūn-bûn

@nan

2008年の論文

@ja

2008年論文

@yue

2008年論文

@zh-hant

2008年論文

@zh-hk

2008年論文

@zh-mo

2008年論文

@zh-tw

2008年论文

@wuu

2008年论文

@zh

2008年论文

@zh-cn

name

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@ast

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@en

type

label

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@ast

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@en

prefLabel

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@ast

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@en

P1433

Q36508920-9AA86A06-C8A4-493E-B550-6B99C6EAA21B

P1476

Q36508920-4240D84D-DF87-46C0-8246-DCE58C4B73DB

P2093

Q36508920-25FFEE1F-A711-46DE-BD95-CF261AAA0C42

Q36508920-7616D898-111A-4F39-9F32-8BC03429A86D

Q36508920-9083CE4B-C884-4CA0-9A9B-713950E809E5

Q36508920-94D6A3A6-F9C7-43BE-B81F-06768B2665E7

Q36508920-A181F41B-BCDE-42BF-8D2A-3FB157171463

Q36508920-AB21A31B-954B-4D5F-A5AB-9C7545D01B33

Q36508920-DF6557CF-6F34-4723-BD77-47AB78003A93

Q36508920-E4318A32-7DB0-4D30-B3F0-479C8030B329

Q36508920-F3222525-C927-478E-A7B8-244F9C28939B

Q36508920-FD4675D3-A51A-40AC-80A4-18E0020832DA

P2860

Q36508920-07B0B5A4-94B5-4398-8555-8EBA70CD094E

Q36508920-1260533F-4AD4-4D33-A1B9-BB498F422C0D

Q36508920-15C5CB04-3A51-45ED-8428-58F00FE966C3

Q36508920-17D57B68-8308-4E6F-BD4D-466823FB4E75

Q36508920-203A8573-7EA9-41A6-B3BB-0AB7FE779F68

Q36508920-20E62D6D-96FE-45C4-AD38-DF743531113C

Q36508920-232919B4-3A16-48F3-B81F-DDA700DDA71C

Q36508920-25E302DA-4A39-4133-92FA-434CAF41DD09

Q36508920-2A20EFA8-11AC-463B-9C30-7C65C216B38C

Q36508920-2BC6DFEC-9DFE-4295-B5A7-401682B7DC38

P304

Q36508920-B4CA9D5F-5CB4-4F00-8F42-0B4B74D6ECD9

P31

Q36508920-F7DBE320-0FAC-4E2A-A51D-CD2FCDA8BC4A

P356

Q36508920-C3DF4C7D-6B31-44FF-96FD-C49493C7DF82

P407

Q36508920-C2385832-23A0-4C24-9B5E-4A6B9FFC3135

P433

Q36508920-4B4EB7AF-D848-4D0D-97CF-9AAFB7C628B2

P478

Q36508920-81F93F12-5D04-4949-9ACB-B8560E8DD9DA

P577

Q36508920-13E1F514-F1E5-41D4-8AA6-397DB805B4AD

P5875

Q36508920-4F9ED62F-8766-4D3C-9915-A3E29E8689A1

P698

Q36508920-87E697A5-5DED-4ABD-B323-2F17D0B03235

P932

Q36508920-3AA3ABBA-F405-4CB5-AA5E-86D2459E231C

P356

BLOOD-2008-01-130146

P1433

P1476

Rabbit ATG but not horse ATG p ...... 3+ regulatory T cells in vitro

@en

P2093

Elena E Solomou

http://www.w3.org/2001/XMLSchema#string

Jichun Chen

http://www.w3.org/2001/XMLSchema#string

Keyvan Keyvanfar

http://www.w3.org/2001/XMLSchema#string

Nalini Raghavachari

http://www.w3.org/2001/XMLSchema#string

Neal S Young

http://www.w3.org/2001/XMLSchema#string

Peter J Munson

http://www.w3.org/2001/XMLSchema#string

Sachiko Kajigaya

http://www.w3.org/2001/XMLSchema#string

Thomas M Herndon

http://www.w3.org/2001/XMLSchema#string

Xingmin Feng

http://www.w3.org/2001/XMLSchema#string

Xiuli Xu

http://www.w3.org/2001/XMLSchema#string

P2860

FOXP3 controls regulatory T cell function through cooperation with NFAT

Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells

Control of regulatory T cell development by the transcription factor Foxp3

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases

An essential role for Scurfin in CD4+CD25+ T regulatory cells

Rabbit antithymocyte globulin induction therapy in adult renal transplantation.

Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis.

Regulatory T cells in the control of immune pathology.

Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance.

P304

3675-3683

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1182/BLOOD-2008-01-130146

http://www.w3.org/2001/XMLSchema#string

P407

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

111

http://www.w3.org/2001/XMLSchema#string

P577

2008-02-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5602606

http://www.w3.org/2001/XMLSchema#string

P698

18250226

http://www.w3.org/2001/XMLSchema#string

P932

2275026

http://www.w3.org/2001/XMLSchema#string